Hegi ME - Search Results

1

Elevated levels of MIC-1/GDF15 in the cerebrospinal fluid of patients are associated with glioblastoma and worse outcome.

Shnaper S, Desbaillets I, Brown DA, Murat A, Migliavacca E, Schluep M, Ostermann S, Hamou MF, Stupp R, Breit SN, de Tribolet N, Hegi ME. Shnaper S, et al. Among authors: hegi me. Int J Cancer. 2009 Dec 1;125(11):2624-30. doi: 10.1002/ijc.24639. Int J Cancer. 2009. PMID: 19521960 Free article.

2

p53 transdominance but no gain of function in mouse brain tumor model.

Hegi ME, Klein MA, Rüedi D, Chène P, Hamou MF, Aguzzi A. Hegi ME, et al. Cancer Res. 2000 Jun 1;60(11):3019-24. Cancer Res. 2000. PMID: 10850451

3

p73 is not mutated in meningiomas as determined with a functional yeast assay but p73 expression increases with tumor grade.

Nozaki M, Tada M, Kashiwazaki H, Hamou MF, Diserens AC, Shinohe Y, Sawamura Y, Iwasaki Y, de Tribolet N, Hegi ME. Nozaki M, et al. Among authors: hegi me. Brain Pathol. 2001 Jul;11(3):296-305. doi: 10.1111/j.1750-3639.2001.tb00400.x. Brain Pathol. 2001. PMID: 11414472 Free PMC article.

4

Anoxia induces macrophage inhibitory cytokine-1 (MIC-1) in glioblastoma cells independently of p53 and HIF-1.

Albertoni M, Shaw PH, Nozaki M, Godard S, Tenan M, Hamou MF, Fairlie DW, Breit SN, Paralkar VM, de Tribolet N, Van Meir EG, Hegi ME. Albertoni M, et al. Among authors: hegi me. Oncogene. 2002 Jun 20;21(27):4212-9. doi: 10.1038/sj.onc.1205610. Oncogene. 2002. PMID: 12082608

5

Classification of human astrocytic gliomas on the basis of gene expression: a correlated group of genes with angiogenic activity emerges as a strong predictor of subtypes.

Godard S, Getz G, Delorenzi M, Farmer P, Kobayashi H, Desbaillets I, Nozaki M, Diserens AC, Hamou MF, Dietrich PY, Regli L, Janzer RC, Bucher P, Stupp R, de Tribolet N, Domany E, Hegi ME. Godard S, et al. Among authors: hegi me. Cancer Res. 2003 Oct 15;63(20):6613-25. Cancer Res. 2003. PMID: 14583454

6

Prognostic factors for low-grade gliomas.

Stupp R, Janzer RC, Hegi ME, Villemure JG, Mirimanoff RO. Stupp R, et al. Among authors: hegi me. Semin Oncol. 2003 Dec;30(6 Suppl 19):23-8. doi: 10.1053/j.seminoncol.2003.11.029. Semin Oncol. 2003. PMID: 14765381 Review.

7

Clinical trial substantiates the predictive value of O-6-methylguanine-DNA methyltransferase promoter methylation in glioblastoma patients treated with temozolomide.

Hegi ME, Diserens AC, Godard S, Dietrich PY, Regli L, Ostermann S, Otten P, Van Melle G, de Tribolet N, Stupp R. Hegi ME, et al. Clin Cancer Res. 2004 Mar 15;10(6):1871-4. doi: 10.1158/1078-0432.ccr-03-0384. Clin Cancer Res. 2004. PMID: 15041700 Clinical Trial.

8

INK4a/Arf is required for suppression of EGFR/DeltaEGFR(2-7)-dependent ERK activation in mouse astrocytes and glioma.

Lachat Y, Diserens AC, Nozaki M, Kobayashi H, Hamou MF, Godard S, De Tribolet N, Hegi ME. Lachat Y, et al. Among authors: hegi me. Oncogene. 2004 Sep 9;23(41):6854-63. doi: 10.1038/sj.onc.1207872. Oncogene. 2004. PMID: 15273738

9

Growth promoting signaling by tenascin-C [corrected].

Ruiz C, Huang W, Hegi ME, Lange K, Hamou MF, Fluri E, Oakeley EJ, Chiquet-Ehrismann R, Orend G. Ruiz C, et al. Among authors: hegi me. Cancer Res. 2004 Oct 15;64(20):7377-85. doi: 10.1158/0008-5472.CAN-04-1234. Cancer Res. 2004. PMID: 15492259

10

MGMT gene silencing and benefit from temozolomide in glioblastoma.

Hegi ME, Diserens AC, Gorlia T, Hamou MF, de Tribolet N, Weller M, Kros JM, Hainfellner JA, Mason W, Mariani L, Bromberg JE, Hau P, Mirimanoff RO, Cairncross JG, Janzer RC, Stupp R. Hegi ME, et al. N Engl J Med. 2005 Mar 10;352(10):997-1003. doi: 10.1056/NEJMoa043331. N Engl J Med. 2005. PMID: 15758010 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

154 results

Search Page